NasdaqGM - Delayed Quote USD
Gain Therapeutics, Inc. (GANX)
1.7300
-0.0700
(-3.89%)
At close: June 13 at 4:00:00 PM EDT
1.8300
+0.10
+(5.78%)
After hours: June 13 at 7:56:33 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.31M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ISLAM KHALID Officer and Director | Purchase at price 1.00 per share. | Direct | 49,940 | Aug 9, 2024 |
| MACK GENE C Chief Executive Officer | Purchase at price 1.01 per share. | Direct | 14,544 | Aug 9, 2024 |
| RICHMAN ERIC I. Director | Purchase at price 1.21 - 1.23 per share. | Direct | 20,670 | Jul 1, 2024 |
| RILEY JEFFREY SCOTT Director | Purchase at price 3.86 per share. | Direct | 115,770 | Mar 28, 2024 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Mar 26, 2024 |
| ALDER MATTHIAS Chief Executive Officer | Sale at price 2.46 per share. | Direct | 507 | Dec 21, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Dec 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | Sale at price 2.50 per share. | Direct | 4,550 | Dec 7, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Sep 29, 2023 |
| RICHMAN ERIC I. Director | -- | Direct | -- | Sep 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Sep 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Jun 30, 2023 |
Related Tickers
COYA Coya Therapeutics, Inc.
5.63
+4.84%
INMB INmune Bio, Inc.
7.70
-2.78%
CHRO Channel Therapeutics Corporation
1.2265
-8.47%
IKNA Ikena Oncology, Inc.
1.3500
-1.46%
NKTX Nkarta, Inc.
1.8600
-2.62%
OBIO Orchestra BioMed Holdings, Inc.
3.0900
-2.22%
QNCX Quince Therapeutics, Inc.
1.4300
+19.17%
ACTU Actuate Therapeutics, Inc. Common stock
8.65
+0.46%
ACRS Aclaris Therapeutics, Inc.
1.4700
-3.92%
CNTX Context Therapeutics Inc.
0.6294
-3.56%